...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Dynamic metabolic profile of Zhi-Zi-Da-Huang decoction in rat urine based on hybrid liquid chromatography-mass spectrometry coupled with solid phase extraction
【24h】

Dynamic metabolic profile of Zhi-Zi-Da-Huang decoction in rat urine based on hybrid liquid chromatography-mass spectrometry coupled with solid phase extraction

机译:基于混合液相色谱-质谱联用固相萃取的智尿大黄汤在大鼠尿液中的动态代谢特征

获取原文
获取原文并翻译 | 示例
           

摘要

Zhi-Zi-Da-Huang decoction (ZZDHD) has been used for treatment of alcoholic liver disease in China for thousands of years. In order to reveal the dynamic biotransformation of the decoction in vivo, a high throughout, sensitive and special method based on high performance liquid chromatography coupled with diode array detection and time-of-flight mass spectrometry (HPLC-DAD-TOF/MS) and high performance liquid chromatography coupled with triple quadrupole mass spectrometry (HPLC-QqQJMS) was developed and validated. 25 parent compounds and 28 metabolites were characterized, among which, two metabolites were found for the first time and tentatively identified by neutral-loss scan and production scan. All the compounds were assigned to iridoids, flavones, anthraquinones, coumarin or p-coumaric acid, and their biotransformation pathways were found to involve glucuronidation, sulfation, reduction and ring cleavage. Glucuronidation occurred as a major metabolic pathway of genipin and flavanone and the conjugates could be detected almost during the whole sampling duration. To compounds such as anthraquinones, coumarin and p-coumaric acid, sulfation is the only transformation pathway and the metabolites were found at 0-12, 4-18, 4-48 h respectively after administration. Reduction and/or ring cleavage of genipin glucuronide and naringin were also observed obviously. The phenomena that parts of parent compounds and metabolites were able to be detected even 48 h after administration implied that the accumulating effect of these constituents in vivo would happen and the potential toxicity of the decoction might appear if multiple dosing is adopted. The strategy used in this paper was proved helpful to offer important information for the clinical safe use of ZZDHD. (C) 2016 Elsevier B.V. All rights reserved.
机译:芝子大黄汤(ZZDHD)在中国已用于治疗酒精性肝病已有数千年的历史。为了揭示汤剂在体内的动态生物转化,基于高效液相色谱,二极管阵列检测和飞行时间质谱(HPLC-DAD-TOF / MS)的高通量,灵敏和特殊方法,以及开发并验证了高效液相色谱与三重四极杆质谱联用(HPLC-QqQJMS)。鉴定了25种母体化合物和28种代谢物,其中首次发现了两种代谢物,并通过中性损失扫描和生产扫描初步鉴定。所有这些化合物都被分配到了烯类化合物,黄酮,蒽醌,香豆素或对香豆酸,并且它们的生物转化途径涉及葡萄糖醛酸化,硫酸化,还原和环断裂。葡糖醛酸化是京尼平和黄烷酮的主要代谢途径,几乎在整个采样期间都可以检测到缀合物。对于蒽醌,香豆素和对香豆酸之类的化合物,硫酸化是唯一的转化途径,并且在施用后分别在0-12、4-18、4-48 h发现了代谢产物。还观察到了Genipin葡糖醛酸苷和柚皮苷的还原和/或环裂解。即使在给药后48小时仍能检测到部分母体化合物和代谢物的现象表明,如果采用多次给药,这些成分会在体内发生累积作用,并且可能会出现汤剂的潜在毒性。事实证明,本文使用的策略有助于为ZZDHD的临床安全使用提供重要信息。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号